Skip to main content
Premium Trial:

Request an Annual Quote

Althea Wins $912K Contract to Develop Plasmid-Based HIV Vaccine for NIAD

NEW YORK (GenomeWeb News) – Althea Technologies said today that Advanced BioScience Laboratories has awarded it a cGMP manufacturing contract worth $911,549 to produce a DNA-based HIV-1 vaccine.
The multi-year contract is under a master agreement with the US National Institutes of Health and funded by the National Institute of Allergy and Infectious Diseases, Althea said.
It will “support Althea's efforts for plasmid DNA process development, vaccine production, purification, and regulatory documentation,” the company said in a statement.
Terms of the deal call for Althea to support a “larger vaccine development program” that is in conjunction with the South African AIDS Vaccine Initiative.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.